SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-270467
Filing Date
2023-11-03
Accepted
2023-11-03 16:43:27
Documents
7
Effectiveness Date
2023-11-03

Document Format Files

Seq Description Document Type Size
1 S-8 d579673ds8.htm S-8 51227
2 EX-5.1 d579673dex51.htm EX-5.1 5324
3 EX-23.1 d579673dex231.htm EX-23.1 2202
4 EX-FILING FEES d579673dexfilingfees.htm EX-FILING FEES 14621
5 GRAPHIC g579673dsp10.jpg GRAPHIC 3778
6 GRAPHIC g579673dsp10s.jpg GRAPHIC 10063
7 GRAPHIC g579673dsp15ajpg.jpg GRAPHIC 18836
  Complete submission text file 0001193125-23-270467.txt   120043
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275315 | Film No.: 231377028
SIC: 2834 Pharmaceutical Preparations